NDC 70771-1679

LENALIDOMIDE

Lenalidomide

LENALIDOMIDE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Lenalidomide.

Product ID70771-1679_e67d1c36-75f9-4c68-b728-4f4995ae0d77
NDC70771-1679
Product TypeHuman Prescription Drug
Proprietary NameLENALIDOMIDE
Generic NameLenalidomide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-09-12
Marketing CategoryANDA /
Application NumberANDA210154
Labeler NameZydus Lifesciences Limited
Substance NameLENALIDOMIDE
Active Ingredient Strength15 mg/1
Pharm ClassesThalidomide Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1679-1

100 CAPSULE in 1 BOTTLE (70771-1679-1)
Marketing Start Date2022-09-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LENALIDOMIDE" or generic name "Lenalidomide"

NDCBrand NameGeneric Name
0378-1936LenalidomideLenalidomide
0378-1937LenalidomideLenalidomide
0378-1940LenalidomideLenalidomide
0378-1941LenalidomideLenalidomide
0480-1242LenalidomideLenalidomide
0480-1243LenalidomideLenalidomide
0480-1244LenalidomideLenalidomide
0480-1246LenalidomideLenalidomide
43598-511LenalidomideLenalidomide
43598-512LenalidomideLenalidomide
43598-513LenalidomideLenalidomide
43598-514LenalidomideLenalidomide
43598-515LenalidomideLenalidomide
43598-516LenalidomideLenalidomide
47781-484LENALIDOMIDELenalidomide
47781-485LENALIDOMIDELenalidomide
47781-486LENALIDOMIDELenalidomide
47781-488LENALIDOMIDELenalidomide
59572-402RevlimidLenalidomide
59572-405RevlimidLenalidomide
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.